Going through the comments all I can see is a significant amount of downramping for this stock. I get the idea that there are a lot of shorters on here.
Allan Gray as a managed fund investor faces some friction from the investors in his fund. This might justify his current offloading of the stock. He might jump in for all you know at a later point. A lot of people are writing this stock off. It hasn't failed as a biotech, it is actually profitable (rare for biotechs) and the court decision has the implication of reducing that potential revenue.The SP has clearly impounded the news. I can't understand why it would sink lower.
The only comment I agree with thus far is what are management actually doing? Do they actually care? I think it is up to us shareholders to use our power to get management on board with the fact we aren't happy and they need to get it together.
In order for the stock to push higher it is all up to management as I see it.
Add to My Watchlist
What is My Watchlist?
